Skip to content

Clinical trials

Phase 3 Liver Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Phase: Phase 3 Country / region: France Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20052
20071
20081
20092
20102
20131
20151
20182
20191
20201
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting4
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Bristol-Myers Squibb3
Bayer2
Abbott1
Assistance Publique - Hôpitaux de Paris1
Eli Lilly and Company1
Exelixis1
Federation Francophone de Cancerologie Digestive1
Hospices Civils de Lyon1
LEO Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms18
Carcinoma, Hepatocellular13
Neoplasms3
Carcinoma2
Adenocarcinoma1
Bile Duct Neoplasms1
Colorectal Neoplasms1
Digestive System Diseases1
Digestive System Neoplasms1
Gallbladder Neoplasms1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.